[at noodls] – December 19, 2012 San Diego – MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that it has completed its previously … moreView todays social media effects on MEIPView the latest stocks trending across Twitter. Click to view dashboardSee who MEI is hiring next, click here […]
[at noodls] – November 19, 2012 MEI Pharma’s Mitochondrial Inhibitor Drug Candidate ME-344 Named One of Top 10 Oncology Products for 2012 San Diego – MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the … moreView todays social media effects on MEIPView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – MEI Pharma reports new data in clinical trial of Pracinostat and Azacitidine Novogen Limited’s subsidiary, MEI Pharma, Inc., (NASDAQ: MEIP) has made the following announcement: San Diego – 6 November, … moreView todays social media effects on MEIPView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – November 6, 2012 MEI Pharma Reports New Data Showing High Response Rates in Clinical Trial of Pracinostat and Azacitidine in Myelodysplastic Syndrome Data Accepted for Presentation at American Society … moreView todays social media effects on MEIPView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – Novogen Limited’s subsidiary, Marshall Edwards, Inc., (NASDAQ: MEIP) has made the following announcement: San Diego – 5 November, 2012- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the … moreView todays social media effects on MEIPView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – November 5, 2012 Financing Led by New Institutional Investors Vivo Ventures and New Leaf Venture Partners San Diego – MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development … moreView todays social media effects on MEIPView the latest stocks trending across Twitter. Click to view dashboard […]
[Other] – Novogen Limited’s subsidiary, Marshall Edwards, Inc., (NASDAQ: MEIP), has made the following announcement: San Diego – 2 October, 2012 – MEI Pharma, Inc., an oncology company focused on the clinical development … moreView todays social media effects on MEIPView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – October 2, 2012 MEI Pharma Issued European Patent for Lead Mitochondrial Inhibitor Drug Candidate ME-344 San Diego – MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development … moreView todays social media effects on MEIPView the latest stocks trending across Twitter. Click to view dashboard […]
